These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2558092)

  • 21. Impaired responses of peripheral blood mononuclear cells to nickel in patients with nickel-allergic contact dermatitis and concomitant atopic dermatitis.
    Buchvald D; Lundeberg L
    Br J Dermatol; 2004 Mar; 150(3):484-92. PubMed ID: 15030331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of polyunsaturated fatty acids in children with atopic dermatitis and in atopic and nonatopic controls.
    Focke M; Sesztak-Greinecker G; Brannath W; Götz M; Jarisch R; Hemmer W
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):485-91. PubMed ID: 16091876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atopic dermatitis and disturbances of essential fatty acid and prostaglandin E metabolism.
    Melnik B; Plewig G
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):859-60. PubMed ID: 1666398
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy.
    Manku MS; Horrobin DF; Morse N; Kyte V; Jenkins K; Wright S; Burton JL
    Prostaglandins Leukot Med; 1982 Dec; 9(6):615-28. PubMed ID: 6961468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Malassezia in atopic dermatitis affecting the head and neck of adults.
    Darabi K; Hostetler SG; Bechtel MA; Zirwas M
    J Am Acad Dermatol; 2009 Jan; 60(1):125-36. PubMed ID: 18834647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral essential fatty acid supplementation in atopic dermatitis-a meta-analysis of placebo-controlled trials.
    van Gool CJ; Zeegers MP; Thijs C
    Br J Dermatol; 2004 Apr; 150(4):728-40. PubMed ID: 15099370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Atopic dermatitis: the first allergic step in children].
    Hofer MF
    Rev Med Suisse Romande; 2000 Mar; 120(3):263-7. PubMed ID: 10815459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production.
    Koning H; Neijens HJ; Baert MR; Oranje AP; Savelkoul HF
    Cytokine; 1997 Jun; 9(6):416-26. PubMed ID: 9199876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immune system and atopic dermatitis.
    Dokmeci E; Herrick CA
    Semin Cutan Med Surg; 2008 Jun; 27(2):138-43. PubMed ID: 18620135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunology of atopic dermatitis.
    Thestrup-Pedersen K
    Acta Derm Venereol Suppl (Stockh); 1989; 151():77-83; discussion 106-10. PubMed ID: 2696310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
    Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
    Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Disturbance of cell-mediated immunoreactions in atopic dermatitis. Reduced spontaneous rosette formation of T lymphocytes (author's transl)].
    Schöpf E
    Dermatologica; 1974; 149(4):210-9. PubMed ID: 4549208
    [No Abstract]   [Full Text] [Related]  

  • 33. Probiotics in the atopic march: highlights and new insights.
    del Giudice MM; Rocco A; Capristo C
    Dig Liver Dis; 2006 Dec; 38 Suppl 2():S288-90. PubMed ID: 17259093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated and IgE-mediated immune responses in atopic dermatitis.
    Clark RA
    Arch Dermatol; 1989 Mar; 125(3):413-6. PubMed ID: 2647030
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
    Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
    Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An allergist's view of atopic dermatitis.
    Berman BA; Kniker WT; Cohen GA
    Dermatol Clin; 1986 Jan; 4(1):55-66. PubMed ID: 3521980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for atopic dermatitis in New Zealand children at 3.5 years of age.
    Purvis DJ; Thompson JM; Clark PM; Robinson E; Black PN; Wild CJ; Mitchell EA
    Br J Dermatol; 2005 Apr; 152(4):742-9. PubMed ID: 15840107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of the T-lymphocyte in atopic dermatitis].
    Nicolas JF; Thivolet J
    Allerg Immunol (Paris); 1989 Sep; 21(7):263-6. PubMed ID: 2789671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of atopic dermatitis following natural measles virus infection. Four case reports.
    Boner AL; Valletta EA; Bellanti JA
    Ann Allergy; 1985 Oct; 55(4):605-8. PubMed ID: 3876791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cellular and humoral immunity in atopic dermatitis].
    Mutevelić-Arslanagić N
    Med Arh; 1998; 52(2):77-9. PubMed ID: 9769640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.